Avanos Medical (AVNS) EPS (Weighted Average and Diluted) (2014 - 2026)
Avanos Medical recorded quarterly EPS (Weighted Average and Diluted) of $0.11 in Q1 2026, up 650.0% quarter-over-quarter from -$0.02 in Q4 2025, and down 21.43% year-over-year from $0.14 in Q1 2025.
Avanos Medical's EPS (Weighted Average and Diluted) history runs 13 years deep, the most recent figure standing at $0.11 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 21.43% year-over-year to $0.11; the TTM figure through Mar 2026 stood at -$1.6 (up 80.51% YoY), while the FY2025 annual figure was -$1.57, up 81.31% from the prior year.
- EPS (Weighted Average and Diluted) came in at $0.11 for Q1 2026 at Avanos Medical, up from -$0.02 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.24 in Q4 2023 to a low of -$8.51 in Q4 2024.
- A 5-year average of -$0.62 and a median of $0.04 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 1300.0% in 2025 and fell as far as 4250.0% in 2025.
- Avanos Medical's EPS (Weighted Average and Diluted) stood at $0.21 in 2022, then grew by 14.29% to $0.24 in 2023, then plunged by 3645.83% to -$8.51 in 2024, then soared by 99.76% to -$0.02 in 2025, then jumped by 650.0% to $0.11 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered $0.11, -$0.02, and -$0.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.11 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | -0.03 |
| Jun 30, 2025 | -1.66 |
| Mar 31, 2025 | 0.14 |
| Dec 31, 2024 | -8.51 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.24 |
| Sep 30, 2023 | -0.19 |
| Jun 30, 2023 | -1.46 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | 0.21 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.10 |
| Mar 31, 2022 | 0.11 |
| Dec 31, 2021 | -0.53 |
| Sep 30, 2021 | -0.73 |
| Jun 30, 2021 | 0.79 |
| Mar 31, 2021 | -0.17 |
| Dec 31, 2020 | -1.03 |
| Sep 30, 2020 | 0.40 |
| Jun 30, 2020 | -0.06 |
| Mar 31, 2020 | 0.08 |
| Dec 31, 2019 | -0.12 |
| Sep 30, 2019 | -0.24 |
| Jun 30, 2019 | -0.17 |
| Mar 31, 2019 | -0.43 |
| Dec 31, 2018 | -0.05 |
| Sep 30, 2018 | 0.09 |
| Jun 30, 2018 | 0.03 |
| Mar 31, 2018 | 0.43 |
| Dec 31, 2017 | 0.69 |
| Sep 30, 2017 | -0.22 |
| Jun 30, 2017 | 0.37 |
| Mar 31, 2017 | -0.32 |
| Dec 31, 2016 | -2.42 |
| Sep 30, 2016 | 0.19 |
| Jun 30, 2016 | 0.14 |
| Mar 31, 2016 | 0.30 |
| Dec 31, 2015 | 7.29 |
| Sep 30, 2015 | -10.10 |
| Jun 30, 2015 | 0.17 |
| Mar 31, 2015 | 0.46 |
| Dec 31, 2014 | -0.05 |
| Sep 30, 2014 | -0.16 |
| Jun 30, 2014 | -0.10 |
| Mar 31, 2014 | 0.89 |